Pacific Edge Limited (PEB.NZ)

0.1550 -0.0060 (-3.73%) At close: 05:00PM NZDT

Pacific Edge Limited

Centre for Innovation
87 St David Street PO Box 56
Dunedin 9016
New Zealand
64 3 577 6733
https://www.pacificedgedx.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Peter Meintjes	Chief Executive Officer	N/A	N/A	N/A
Mr. Grant Gibson	Chief Financial Officer	N/A	N/A	N/A
Mr. Darrell Morgan	Chief Operating Officer	N/A	N/A	N/A
Dr. Justin Harvey	Chief Technology Officer	N/A	N/A	N/A
Prof. Parry Guilford Ph.D.	Chief Scientific Officer & Member of Scientific Advisory Board	134k	N/A	N/A
Mr. Andrew McIntosh	Chief Digital Officer	N/A	N/A	N/A
Glen Costin	President of Asia Pacific	N/A	N/A	N/A
Dr. Tamer Aboushwareb	Chief Medical Officer	N/A	N/A	N/A
Mr. David Levison	Executive Chairman & President of Pacific Edge Diagnostics USA	53k	N/A	1960

Amounts are as of 31 December 2009, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in NZD.

Description

Pacific Edge Limited, a cancer diagnostics company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, and internationally. It operates through two segments, Commercial and Research. The company offers Cxbladder, a genomic urine biomarker test for the detection and surveillance of bladder cancer. It also develops Cxbladder Triage, a frontline diagnostic product that helps de-intensify clinical work-up for patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect, which enables the risk stratification of patients with haematuria; and Cxbladder Monitor, a non-invasive surveillance alternative that reduces the burden of repeated cystoscopy in patients with a low risk of recurrence. In addition, the company is developing products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

Corporate governance

Pacific Edge Limited’s ISS governance QualityScore as of 1 October 2024 is 3. The pillar scores are Audit: 7; Board: 2; Shareholder rights: 5; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.